| |
Bergen 4-day
|
Effectiveness
|
Statistic
|
|---|
|
N
|
M (SD)
|
N
|
M (SD)
|
t-test (p)
|
|---|
|
Y-BOCS
|
|
Pre
|
90
|
26.2 (3.4)
|
381
|
24.4 (5.4)
|
3.02 (=.0026)
|
|
Post
|
90
|
10.5 (4.6)
|
374
|
18.2 (7.0)
|
9.93 (<.0001)
|
|
3 months
|
90
|
10.7 (6.3)
|
317
|
16.2 (8.1)
|
5.95 (<.0001)
|
|
Remission
|
Fisher’s test
|
|
Post
|
90
|
72.2%
|
110
|
35.5%
|
p < .0001
|
|
3 months
|
90
|
67.8%
|
110
|
45.5%
|
p = .0017
|
- Note: Data for effectiveness studies were taken from uncontrolled studies of ERP having 3–6 month follow-up. N indicates the total number of participants across these studies. Remission was calculated as ≥35% reduction of pre-treatment Y-BOCS scores and ≤ 12 on post and follow-up Y-BOCS
